A Role for Insulin-Like Growth Factor in the Regulation of IL-6-Responsive Human Myeloma Cell Line Growth

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 487-496

  Jelinek, Diane F ^a   Witzig, Thomas E ^b   Arendt, Bonnie K ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SOMATOMEDIN B; SOMATOMEDIN C;

ARTICLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY;

CELL DIVISION; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-6; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED;

EID: 0031181228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kawano, M., T. Hirano, T. Mutsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332:83.
2. Zhang, X. G., J. J. Gu, Z. Y. Lu, K. Yasukawa, G. D. Yancopoulos, K. Turner, M. Shoyab, T. Taga, T. Kishimoto, R. Bataille, and B. Klein. 1994. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 177:1337.
3. Nishimoto, N., A. Ogata, Y. Shima, Y. Tani, H. Ogawa, M. Nakagawa, H. Sugiyama, K. Yoshizaki, and T. Kishimoto. 1994. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plusmacytoma cells via the common signal transducer. gp130. J. Exp. Med. 179:1343.
4. Westendorf, J. J., and D. F. Jelinek. 1996. Growth regulatory pathways in myeloma: evidence For autocrine oncostatin M expression. J. lmmunol. 157:3081.
5. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nukajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differemtation of B cells. J. Exp. Med. 167:332.
6. Splawski, J. B., L. M. McAnally, and P. E. Lipsky. 1990. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (HSF-2). J. Immunol. 114:562.
7. Busergu, R., and R. Rubin. 1993. Cell cycle and growth control. Crit. Rev. Eukaryotic Gene Expr. 3:47.
8. Jones, J. I., and D. R. Clemmons. 1995. Insulin-like growth factors and their binding proteins: biological actions. Enodcr. Rev. 16:3.
9. Cohick, W. S., and D. R. Clemmons. 1993. The insulin-like growth factors. Anuu. Rev. Physiol. 55:131.
10. Buserga, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:249.
11. Macaulay, V. M. 1992. Insulin-like growth factors and cancer. Br. J. Cancer 65:311.
12. Cullen, K. J., D. Yee, and N. Rosen. 1991. Insulinlike growth factors in human malignancy. Cancer Invest. 9:443.
13. Christofori, G., P. Naik, and D. Hanahan. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414.
14. Sell, C., M. Rubini, R. Rubin, J-P. Liu, A. Efstratiadis, and R. Baserga. 1993. Simian virus 40 large minor antigen is unable to transform mouse emhryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad. Sci. USA 90:11217.
15. Sell, C., G. Dumenil, C. Deveaud, M. Miura, D. Coppola, T. De Angelis, R. Rubin, A. Efstratiadis, and R. Baserga. 1994. Effect of a null mutation of the type l IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604.
16. Kaleko, M., W. J. Rutter, and A. D. Miller. 1990. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10:464.
17. Long, L., R. Rubin, R. Baserga, and P. Brodt. 1995. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res. 55:1006.
18. Prager, D., H.-L. Li, S. Asa, and S. Melmed. 1994. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA 91:2181.
19. Freund, G. G., D. T. Kulas, and R. A. Mooney. 1993. Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPM1 8226. J. Immunol. 151:1811.
20. Freund, G. G., D. T. Kulas, B. A. Way, and R. A. Mooney. 1994. Functional insulin and insulin-like growth factor-l receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Cancer Res. 54:3179.
21. Kimata, H., and A. Yoshida. 1994. Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. Blood 83:1569.
22. Georgii-Hemming, P., H. J. Wiklund, O. Ljunggren, and K. Nilsson. 1996. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 88:2250.
23. Jernberg, H., M. Pettersson, T. Kishimoto, and K. Nilsson. 1991. Heterogeneity in response to interleukin 6 (IL-6). expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Leukemia 5:255.
24. Jelinek, D. F., G. J. Ahmann, P. R. Greipp, S. M. Jalal, J. J. Westendorf, J. A. Katzmann, R. A. Kyle, and J. A. Lust. 1993. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer Res. 53:5320.
25. Westendorf, J. J., G. J. Ahmann, P. R. Greipp, T. E. Witzig, R. A. Kyle, J. A. Lust, and D. F. Jelinek. 1996. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia 10:866.
26. Aagaard-Tillery, K. M., and D. F. Jelinek. 1995. Differential activation of a calcium-dependent endonuclease in human B lymphocytes: role in ionomycin-induced apoptosis. J. Immunol. 155:3297.
27. Hirohata, S., D. F. Jelinek, and P. E. Lipsky. 1988. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J. Immunol. 40:3726.
28. Thiele, D. L., M. Kurosaka, and P. E. Lipsky. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in the human peripheral blood: delineation by its sensitivity to the lysosomotropic agent L-leucine methyl ester. J. Immunol. 131:2282.
29. Jelinek, D. F., and P. E. Lipsky. 1985. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells. J. Immunol. 134: 1690.
30. Pei, G., M. Tiberi, M. G. Caron, and R. J. Lefkowitz. 1994. An approach to the study of G-protein-coupled receptor kinases: an in vitro purified membrane assay reveals differential receptor specificity and regulation by Gβγ subunits. Proc. Natl. Acad. Sci. USA 91:3633.
31. Westendorf, J. J., G. J. Ahmann, R. J. Amitage, M. K. Spriggs, J. A. Lust, P. R. Greipp, J. A. Katzmann, and D. F. Jelinek. 1994. CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 152:117.
32. James, S. P. Measurement of basic immunologic characteristics of human mononuclear cells, In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, pp. 7.10.1-7.10.10.
33. Stuart, C. A., R. T. Meehan, L. S. Neale, N. M. Cintron, and R. W. Furlanetto. 1991. Insulin-like growth factor-I binds selectively to human peripheral blood monoyytes and B-lymphocytcs. J. Clin. Endocrinol. Metab. 72:1117.
34. Jelinek, D. F., J. B. Splawski, and P. E. Lipsky. 1986. The roles of interleukin 2 and IFN-γ in human B cell activation, growth, and differentiation. Eur. J. Immunol. 16:925.
35. Jelinek, D. F., and P. E. Lipsky. 1983. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J. Immunol. 130:2597.
36. Amoroso, K., and P. E. Lipsky. 1990. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells. J. Immunol. 145:3155.
37. Lee, P. D., R. G. Rosenfeld, R. L. Hintz, and S. D. Smith. 1986. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J. Clin. Endocrinol Metab. 62:28.
38. LeRoith, D., H. Werner, D. Beitner-Johnson, and C. T. Roberts. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:143.
39. Coppola, D., A. Ferber, M. Miura, C. Sell, C. D'Ambrosio, R. Rubin, and R. Baserga. 1994. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14:4588.
40. Fiorelli, G., C. Orlando, S. Benvenuti, F. Franceschelli, S. Blanchi, P. Pioli, A. Tanini, M. Serio, F. Bartucci, and M. L. Brandi. 1994. Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells. J. Bone Miner. Res. 9:329.
41. Middleton, J., N. Arnott, S. Walsh, and J. Beresford. 1995. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 16:287.
42. Snowden, J. A., M. Greaves, and K. Page. 1994. Reversal of diabetes associated with escape of myeloma: evidence for inappropriate IGF-II secretion. Br. J. Haematol. 87:202.